The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
5-Amino-2-hydroxybenzoic Acid 4-(5-Thioxo-5 H-[1,2]dithiol-3yl)-phenyl Ester (ATB-429), a Hydrogen Sulfide-Releasing Derivative of Mesalamine, Exerts Antinociceptive Effects in a Model of Postinflammatory Hypersensitivity
Abstract
H(2)S functions as a neuromodulator and exerts anti-inflammatory activities. Recent data indicate that irritable bowel syndrome (IBS) is linked to inflammation of the gastrointestinal tract. In this study, we have investigated the role of a novel H(2)S-releasing derivative of mesalamine (5-amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester, ATB-429) in modulating nociception to colorectal distension (CRD), a model that mimics some features of IBS, in healthy and postcolitic rats. Four graded (0.4-1.6 ml of water) CRDs were produced in conscious rats, and colorectal sensitivity and pain were assessed by measuring the abdominal withdrawal response and spinal c-Fos expression. In healthy rats, ATB-429 dose dependently (25, 50, or 100 mg/kg) attenuated CRD-induced hypersensitivity and significantly inhibited CRD-induced overexpression of spinal c-FOS mRNA, whereas mesalamine had no effect. ATB-429-induced antinociception was reversed by glibenclamide, a ATP-sensitive K(+) (K(ATP)) channel inhibitor. The antinociceptive effect of ATB-429 was maintained in a rodent model of postinflammatory hypersensitivity (4 weeks after colitis induction). At a dose of 100 mg/kg, ATB-429 reversed the allodynic response caused by CRD in postcolitic rats. Colonic cyclooxygenase-2 and interkeukin-1beta mRNA and spinal c-FOS mRNA expression were significantly down-regulated by ATB-429, but not by mesalamine. ATB-429, but not mesalamine, increased blood concentrations of H(2)S in both healthy and postcolitic rats. Taken together, these data suggest that ATB-429 inhibits hypersensitivity induced by CRD in both healthy and postcolitic, allodynic rats by a K(ATP) channel-mediated mechanism. This study provides evidence that H(2)S-releasing drugs might have beneficial effects in the treatment of painful intestinal disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, mesalamine 3.2 g/day for 12 wk (168) and prednisolone 30 mg/day for 3 wk (52) were not effective in improving the GI symptoms in patients with PI-IBS.”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [52]
Citations
Cites
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
The possible role of hydrogen sulfide as an endogenous neuromodulator
Abe, K., & Kimura, H. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01066.1996 · Cited by 2,240
The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener
Zhao, W., Zhang, J., Lu, Y., & Wang, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6008 · Cited by 1,936
Two's company, three's a crowd: can H 2 S be the third endogenous gaseous transmitter?
Wang, R. T. (2002) · The FASEB Journal · doi:10.1096/fj.02-0211hyp · Cited by 1,808
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475
Hydrogen sulfide is a novel mediator of lipopolysaccharide‐induced inflammation in the mouse
Li, L., Bhatia, M., Zhu, Y. Z., Zhu, Y. C., Ramnath, R. D., Wang, Z. J., Anuar, F., Whiteman, M., Salto‐Tellez, M., & Moore, P. K. (2005) · The FASEB Journal · doi:10.1096/fj.04-3583fje · Cited by 773
Al–Chaer, E. D., Kawasaki, M., & Pasricha, P. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.19576 · Cited by 727
Visceral pain: a review of experimental studies
Ness, T. J., & Gebhart, G. F. (1990) · Pain · doi:10.1016/0304-3959(90)90021-5 · Cited by 605
Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
Sartor, R. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90614-9 · Cited by 595
The Pharmacology of ATP-Sensitive Potassium Channels
Edwards, G., & Weston, A. H. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.003121 · Cited by 529
Cited by
Sorted by citations
Hydrogen sulphide and its therapeutic potential
Szabó, C. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2425 · Cited by 2,039
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
Wang, R. (2012) · Physiological Reviews · doi:10.1152/physrev.00017.2011 · Cited by 1,962
Chemical Biology of H 2 S Signaling through Persulfidation
Filipović, M. R., Živanović, J., Álvarez, B., & Banerjee, R. V. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00205 · Cited by 1,059
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter
Wallace, J. L., & Wang, R. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4433 · Cited by 882
Self-citationHydrogen sulfide as a gasotransmitter
Gadalla, M. M., & Snyder, S. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06580.x · Cited by 493
Szabó, C., & Papapetropoulos, A. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.014050 · Cited by 423
Hydrogen sulfide (H 2 S) releasing agents: chemistry and biological applications
Zhao, Y., Biggs, T. D., & Xian, M. (2014) · Chemical Communications · doi:10.1039/c4cc00968a · Cited by 356
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative
Li, L., Rossoni, G., Sparatore, A., Lee, L. C., Soldato, P. D., & Moore, P. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.011 · Cited by 346
Hydrogen sulfide-releasing anti-inflammatory drugs
Wallace, J. L. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.09.003 · Cited by 328
Self-citationBiology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras
Kashfi, K., & Olson, K. R. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.019 · Cited by 315
Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air?
Li, L., & Moore, P. A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.003 · Cited by 308
Whiteman, M., Trionnaire, S. L., Chopra, M., Fox, B. C., & Whatmore, J. L. (2011) · Clinical Science · doi:10.1042/cs20110267 · Cited by 310
Caliendo, G., Cirino, G., Santagada, V., & Wallace, J. L. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901638j · Cited by 272
Self-citationWallace, J. L., Caliendo, G., Santagada, V., Cirino, G., & Fiorucci, S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.042 · Cited by 271
Self-citationHydrogen Sulfide: An Endogenous Mediator of Resolution of Inflammation and Injury
Wallace, J. L., Ferraz, J. G., & Muscará, M. N. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4351 · Cited by 234
Self-citationMarkedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)
Wallace, J. L., Caliendo, G., Santagada, V., & Cirino, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00611.x · Cited by 231
Self-citationFiorucci, S., Orlandi, S., Mencarelli, A., Caliendo, G., Santagada, V., Distrutti, E., Santucci, L., Cirino, G., & Wallace, J. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707193 · Cited by 212
Self-citationLuminal sulfide and large intestine mucosa: friend or foe?
Blachier, F., Davila, A., Mimoun, S., Bénetti, P.-H., Atanasiu, C., Andriamihaja, M., Benamouzig, R., Bouillaud, F., & Tomé, D. (2009) · Amino Acids · doi:10.1007/s00726-009-0445-2 · Cited by 210
Hydrogen sulfide and nitric oxide interactions in inflammation
Faro, M. L. L., Fox, B., Whatmore, J. L., Winyard, P. G., & Whiteman, M. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.05.014 · Cited by 214
Toward Hydrogen Sulfide Based Therapeutics: Critical Drug Delivery and Developability Issues
Zheng, Y., Yu, B., Cruz, L. K. D. L., Choudhury, M. R., Anifowose, A., & Wang, B. (2017) · Medicinal Research Reviews · doi:10.1002/med.21433 · Cited by 175
Interaction of hydrogen sulfide with ion channels
Tang, G., Wu, L., & Wang, R. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05351.x · Cited by 157
Gut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System Homeostasis
Tomášová, L., Konopelski, P., & Ufnal, M. (2016) · Molecules · doi:10.3390/molecules21111558 · Cited by 161
Anti-Inflammatory and Cytoprotective Actions of Hydrogen Sulfide: Translation to Therapeutics
Wallace, J. L., Blackler, R. W., Chan, M. V., Da Silva, G. J., Elsheikh, W., Flannigan, K. L., Gamaniek, I., Manko, A., Wang, L., Motta, J.-P., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5901 · Cited by 156
Self-citationRole of Hydrogen Sulfide in Ischemia-Reperfusion Injury
Wu, D., Wang, J., Li, H., Xue, M., Ji, A., & Li, Y. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/186908 · Cited by 147
Hydrogen sulfide in pharmacology and medicine – An update
Bełtowski, J. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.01.005 · Cited by 148
Emerging role of hydrogen sulfide in colonic physiology and pathophysiology
Medani, M., Collins, D., Docherty, N. G., Baird, A. W., O’Connell, P. R., & Winter, D. C. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21528 · Cited by 142
Hydrogen sulfide and nitric oxide interactions in inflammation
Whiteman, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.021 · Cited by 141
Physiological and Pathophysiological Roles of Hydrogen Sulfide in the Gastrointestinal Tract
Wallace, J. L. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2900 · Cited by 131
Self-citationHydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors
Zaorska, E., Tomášová, L., Koszelewski, D., Ostaszewski, R., & Ufnal, M. (2020) · Biomolecules · doi:10.3390/biom10020323 · Cited by 130
Inhaled Hydrogen Sulfide Protects against Ventilator-induced Lung Injury
Faller, S., Ryter, S. W., Choi, A. M. K., Loop, T., Schmidt, R., & Hoetzel, A. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181de7107 · Cited by 124
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome
Ringel, Y., & Maharshak, N. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00207.2012 · Cited by 115
Gaseous mediators in resolution of inflammation
Wallace, J. L., Ianaro, A., Flannigan, K. L., & Cirino, G. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.05.004 · Cited by 109
Self-citationSystematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome
Qin, H., Wu, J. C. Y., Tong, X.-D., Sung, J. J. �., Xu, H., & Bian, Z. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0321-6 · Cited by 111
Distrutti, E., Cipriani, S., Mencarelli, A., Renga, B., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063893 · Cited by 107
Self-citationNonsteroidal Anti‐Inflammatory Therapy: A Journey Toward Safety
Pereira‐Leite, C., Nunes, C., Jamal, S. K., Cuccovia, I. M., & Reis, S. (2016) · Medicinal Research Reviews · doi:10.1002/med.21424 · Cited by 108
Zhou, Y., Chen, W., Zhu, J., Pei, W., Wang, C., Huang, L., Yao, C., Yan, Q., Huang, W., Loo, S. C. J., et al. (2014) · Small · doi:10.1002/smll.201401867 · Cited by 102
Chan, M. V., & Wallace, J. L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00169.2013 · Cited by 98
Self-citationChattopadhyay, M., Kodela, R., Nath, N., Barsegian, A., Boring, D. L., & Kashfi, K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.019 · Cited by 96
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: What lies beyond the horizon
Fiorucci, S., Santucci, L., & Distrutti, E. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.09.001 · Cited by 92
Self-citationMast cells and nerves tickle in the tummy
Rijnierse, A., Nijkamp, F. P., & Kraneveld, A. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.008 · Cited by 105
Dual role of hydrogen sulfide in mechanical inflammatory hypernociception
Cunha, T. M., Dal-Secco, D., Verri, W. A., Jr., Guerrero, A. T. G., de Souza, G. R., Vieira, S. M., Lotufo, C. M. D. C., Neto, A. F., Ferreira, S. H., & Cunha, F. Q. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.05.048 · Cited by 89
Anti-Inflammatory Agents as Cancer Therapeutics
Kashfi, K. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57002-5 · Cited by 87
Progress and perspective on hydrogen sulfide donors and their biomedical applications
Song, Z., Zhao, L., Ma, T., Osama, A., Shen, T., He, Y., & Fang, J. (2022) · Medicinal Research Reviews · doi:10.1002/med.21913 · Cited by 87
Talley, N. J. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01217.x · Cited by 87
Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells
Pei, Y., Wu, B., Cao, Q., Wu, L., & Yang, G. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.09.026 · Cited by 85
Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid
Isenberg, J. S., Jia, Y., Field, L., Ridnour, L. A., Sparatore, A., Soldato, P. D., Sowers, A. L., Yeh, G. C., Moody, T. W., Wink, D. A., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707198 · Cited by 86
Xu, G.-Y., Winston, J. H., Shenoy, M. M., Zhou, S., Chen, J. D. Z., & Pasricha, P. J. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-44 · Cited by 83
Design and Synthesis of Polymeric Hydrogen Sulfide Donors
Hasegawa, U., & van der Vlies, A. J. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500150s · Cited by 80
Anti-inflammatory and Cytoprotective Properties of Hydrogen Sulfide
Gemici, B., & Wallace, J. L. (2015) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2014.11.034 · Cited by 79
Self-citationH2S Donors and Their Use in Medicinal Chemistry
Magli, E., Perissutti, E., Santagada, V., Caliendo, G., Corvino, A., Esposito, G., Esposito, G., Fiorino, F., Migliaccio, M., Scognamiglio, A., et al. (2021) · Biomolecules · doi:10.3390/biom11121899 · Cited by 78
Self-citationTherapeutic potential of new hydrogen sulfide-releasing hybrids
Sparatore, A., Santus, G., Giustarini, D., Rossi, R., & Soldato, P. D. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.122 · Cited by 78
Ogawa, H., Takahashi, K., Miura, S., Imagawa, T., Saito, S., Tominaga, M., & Ohta, T. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.044 · Cited by 76
van den Berg, E., Pasch, A., Westendorp, W. H., Navis, G. J., Brink, E. J., Gans, R. O. B., van Goor, H., & Bakker, S. J. L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050497 · Cited by 76
Feng, S., Zhao, Y., Xian, M., & Wang, Q. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.010 · Cited by 74
Hirata, I., Naito, Y., Takagi, T., Mizushima, K., Suzuki, T., Omatsu, T., Handa, O., Ichikawa, H., Ueda, H., & Yoshikawa, T. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1461-5 · Cited by 72
TRPA1 Has a Key Role in the Somatic Pro-Nociceptive Actions of Hydrogen Sulfide
Andersson, D. A., Gentry, C., & Bevan, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046917 · Cited by 71
Development of Hydrogen Sulfide-Based Therapeutics for Cardiovascular Disease
Predmore, B. L., & Lefer, D. J. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9201-y · Cited by 65
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets
Fagone, P., Mazzon, E., Bramanti, P., Bendtzen, K., & Nicoletti, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.026 · Cited by 62
Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide
Bannenberg, G. L., & Vieira, H. L. A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902858824 · Cited by 62
Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis
Zhang, H., Bai, Z., Zhu, L., Liang, Y., Fan, X., Li, J., Wen, H., Shi, T., Zhao, Q., & Wang, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112665 · Cited by 60
The dichotomous role of H2S in cancer cell biology? Déjà vu all over again
Kashfi, K. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.042 · Cited by 59
Lee, A. T.-H., Shah, J. J., Li, L., Cheng, Y., Moore, P. K., & Khanna, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.11.052 · Cited by 55
Medicinal Chemistry: Insights into the Development of Novel H2S Donors
Zhao, Y., Pacheco, A., & Xian, M. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-18144-8_18 · Cited by 54
Hydrogen sulfide in cell survival: a double-edged sword
Yang, G. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.131 · Cited by 54
Hydrogen sulfide in hemostasis: Friend or foe?
Olas, B. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.04.006 · Cited by 47
Calcium sulfide (CaS), a donor of hydrogen sulfide (H2S): A new antihypertensive drug?
Li, Y., Chuan-shi, X., & Hui, R. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.03.030 · Cited by 45
Módis, K., Wolanska, K. I., & Vozdek, R. (2013) · General Physiology and Biophysics · doi:10.4149/gpb_2013001 · Cited by 44
Farrell, K. E., Keely, S., Graham, B. A., Callister, R., & Callister, R. J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437499.52922.b1 · Cited by 43
Hydrogen Sulphide Induces μ Opioid Receptor-Dependent Analgesia in a Rodent Model of Visceral Pain
Distrutti, E., Cipriani, S., Renga, B., Mencarelli, A., Migliorati, M., Cianetti, S., & Fiorucci, S. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-36 · Cited by 43
Self-citationBuilding a better aspirin: gaseous solutions to a century‐old problem
Wallace, J. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707396 · Cited by 43
Self-citationHerrera, B. S., Coimbra, L. S., da Silva, A. R., Teixeira, S. A., Costa, S. K. P., Wallace, J. L., Spolidório, L. C., & Muscará, M. N. (2015) · Medical Gas Research · doi:10.1186/s13618-015-0025-3 · Cited by 41
Self-citationRole of Gut Microbial Metabolites in Cardiovascular Diseases—Current Insights and the Road Ahead
Datta, S., Pasham, S., Sandeep, I. S., Boini, K. M., & Koka, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810208 · Cited by 42
Fonseca, M. M., Cunha, F. Q., Kashfi, K., & Cunha, T. M. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.133 · Cited by 39
Hydrogen Sulfide’s Involvement in Modulating Nociception
Smith, H. S. (2009) · Pain Physician · doi:10.36076/ppj.2009/12/901 · Cited by 39
Zaorska, E., Hutsch, T., Gawryś-Kopczyńska, M., Ostaszewski, R., Ufnal, M., & Koszelewski, D. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102941 · Cited by 38
Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice
Li, H., Zhang, Z., Zhang, Q.-X., Qin, Z., He, D., & Chen, J. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-012-2584-5 · Cited by 38
Brzozowski, T., Konturek, P. C., Śliwowski, Z., Drozdowicz, D., Burnat, G., Pajdo, R., Pawlik, M., Bielański, W., Kato, I., Kuwahara, A., et al. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.02.003 · Cited by 37
The hydrogen sulfide donor, Lawesson's reagent, prevents alendronate-induced gastric damage in rats
Nicolau, L. A. D., Silva, R. O., Damasceno, S., Carvalho, N. S., Costa, N. R. D., Aragão, K. S., Barbosa, A. L. D. R., Soares, P. M. G., de Souza, M. H. L. P., & Medeiros, J. V. R. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20133030 · Cited by 37
Zanatta, S. D., Jarrott, B., & Williams, S. J. (2010) · Australian Journal of Chemistry · doi:10.1071/ch09517 · Cited by 37
Costa, S. K. P., Muscará, M. N., Allain, T., Dallazen, J. L., Santos, L. G., Buret, A. G., Vaughan, D. J., Fowler, C. J., Nucci, G. D., & Wallace, J. L. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7884 · Cited by 36
Self-citationRole of hydrogen sulfide in the formalin-induced orofacial pain in rats
Donatti, A. F., Araujo, R. M., Soriano, R. N., Azevedo, L. U., Leite‐Panissi, C. R. A., & Branco, L. G. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.023 · Cited by 35
Azlina, M. F. N., Ibrahim, I. A. A., Kamisah, Y., & Ismail, N. M. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-54 · Cited by 33
Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo
Chattopadhyay, M., Kodela, R., Nath, N., Street, C. R., Velázquez‐Martínez, C. A., Boring, D. L., & Kashfi, K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.020 · Cited by 32
Mostafa, D. K., Azhary, N. M. E., & Nassra, R. A. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0316 · Cited by 31
Sikora, M., Drapała, A., & Ufnal, M. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2014.04.004 · Cited by 30
Kshirsagar, V. V., Thingore, C., Gursahani, M., Gawali, N. B., & Juvekar, A. R. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00374-6 · Cited by 30
Bass, S. E., Sienkiewicz, P., MacDonald, C. J., Cheng, R. Y. S., Sparatore, A., Soldato, P. D., Roberts, D. D., Moody, T. W., Wink, D. A., & Yeh, G. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1870 · Cited by 29
Yu, B., Kang, T., Xu, Y., Liu, Y., Ma, Y., & Ke, B. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202201668 · Cited by 28
Role of hydrogen sulfide in visceral nociception
Schemann, M., & Grundy, D. (2009) · Gut · doi:10.1136/gut.2008.167858 · Cited by 28
Szlachcic, A., Śliwowski, Z., Krzysiek-Mączka, G., Majka, J., Surmiak, M., Pajdo, R., Drozdowicz, D., Konturek, S. J., & Brzozowski, T. (2013) · Peptides · doi:10.1016/j.peptides.2013.07.017 · Cited by 27
Fargher, H. A., Lau, N., Zakharov, L. N., Haley, M. M., Johnson, D. W., & Pluth, M. D. (2018) · Chemical Science · doi:10.1039/c8sc03968b · Cited by 26
Hydrogen sulfide: Recent development of its dual donors and hybrid drugs
Xu, S. J., Shieh, M., Paul, B. D., & Xian, M. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16211 · Cited by 25
Hydrogen sulfide and the metabolic syndrome
Desai, K. M., Chang, T., Untereiner, A. A., & Wu, L. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.133 · Cited by 24
Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Ulcer: Looking to the Future
Fiorucci, S. (2009) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.03.001 · Cited by 23
Self-citationGür, S., Kadowitz, P. J., Sikka, S. C., Peak, T. C., & Hellstrom, W. J. G. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.08.005 · Cited by 21
Zhao, L., Xiao, Y., Weng, R., Liu, X., Zhang, P., Hu, C.-Y., Yu, S. P., & Xu, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00696 · Cited by 18
Deiteren, A., Vermeulen, W., Moreels, T. G., Pelckmans, P. A., Man, J. G. D., & Winter, B. Y. D. (2014) · Stress · doi:10.3109/10253890.2014.951034 · Cited by 17
Wiliński, B., Wiliński, J., Somogyi, E., Góralska, M., & Piotrowska, J. (2011) · Folia Biologica · doi:10.3409/fb59_1-2.41-44 · Cited by 16
Distrutti, E., Mencarelli, A., Renga, B., Caliendo, G., Santagada, V., Severino, B., & Fiorucci, S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.008 · Cited by 15
Self-citationResearch Progress of H2S Donors Conjugate Drugs Based on ADTOH
Wen, S., Cao, C., Ge, J., Yang, W., Wang, Y., & Mou, Y. (2022) · Molecules · doi:10.3390/molecules28010331 · Cited by 14
Metadata
- Authors
- Distrutti, E., Sediari, L., Mencarelli, A., Renga, B., Orlandi, S., Russo, G., Caliendo, G., Santagada, V., Cirino, G., Wallace, J. L., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- ORCID
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 319
- Issue
- 1
- Pages
- 447-458
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2166470604
- Cited by
- 144
- References
- 41
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 2 · 2022: 9 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 5 · 2015: 12 · 2014: 13 · 2013: 14 · 2012: 6
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Keywords
- hydrogen sulfide, 5-aminosalicylic acid, irritable bowel syndrome, colorectal distension, antinociception, ATP-sensitive potassium channels, glibenclamide, Fos expression, cyclooxygenase-2, IL-1β, colitis, allodynia, visceral pain, neuromodulation
- MeSH terms
- Analgesics, Animals, Colon, Disulfides, Hydrogen Sulfide, Male, Spinal Cord, Rats, Wistar, Mesalamine, Potassium Channel Blockers, Irritable Bowel Syndrome, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review